Influence of hypothalamic IL-6/gp130 receptor signaling on the HPA axis response to chronic stress

Psychoneuroendocrinology

Volumn 38, Issue 7, 2013, Pages 1158-1169

  Girotti, Milena ^a   Donegan, Jennifer J ^a   Morilak, David A ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

Chronic stress; HPA axis; Hypothalamus; Interleukin 6; JAK STAT signaling

Indexed keywords

CORTICOSTERONE; GLYCOPROTEIN GP 130; INTERLEUKIN 6 RECEPTOR; JANUS KINASE; NEUTRALIZING ANTIBODY; PROTEIN INHIBITOR; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3;

ACUTE STRESS; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN FUNCTION; CHRONIC STRESS; CHRONIC UNPREDICTABLE STRESS; COLD STRESS; CONTROLLED STUDY; DEPRESSION; FOOTSHOCK; HORMONE RESPONSE; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INTRACELLULAR SIGNALING; MALE; METABOLIC STRESS; NERVE CELL PLASTICITY; NEUROENDOCRINE SYSTEM; NEUROTRANSMISSION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; QUALITATIVE ANALYSIS; RAT; RECEPTOR BLOCKING;

ANIMALS; COLD TEMPERATURE; CYTOKINE RECEPTOR GP130; ELECTROSHOCK; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; HYPOTHALAMUS; INTERLEUKIN-6; MALE; PHOSPHORYLATION; PITUITARY-ADRENAL SYSTEM; RATS; RATS, SPRAGUE-DAWLEY; STRESS, PHYSIOLOGICAL;

EID: 84877921458     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2012.11.004     Document Type: Article

References (66)

1. Abelson J.L., Khan S., Liberzon I., Young E.A. HPA axis activity in patients with panic disorder: review and synthesis of four studies. Depress. Anxiety 2007, 24:66-76.
2. Aguilera G., Rabadan-Diehl C. Regulation of vasopressin V1b receptors in the anterior pituitary gland of the rat. Exp. Physiol. 2000, 85 Spec No: 19S-26S.
3. Auernhammer C.J., Melmed S. Leukemia-inhibitory factor-neuroimmune modulator of endocrine function. Endocr. Rev. 2000, 21:313-345.
4. Bhatnagar S., Meaney M.J. Hypothalamic-pituitary-adrenal function in chronic intermittently cold-stressed neonatally handled and non handled rats. J. Neuroendocrinol. 1995, 7:97-108.
5. Blandino P., Barnum C.J., Deak T. The involvement of norepinephrine and microglia in hypothalamic and splenic IL-1beta responses to stress. J. Neuroimmunol. 2006, 173:87-95.
6. Bondi C.O., Rodriguez G., Gould G.G., Frazer A., Morilak D.A. Chronic unpredictable stress induces a cognitive deficit and anxiety-like behavior in rats that is prevented by chronic antidepressant drug treatment. Neuropsychopharmacology 2008, 33:320-331.
7. Bosker F.J., Westerink B.H., Cremers T.I., Gerrits M., van der Hart M.G., Kuipers S.D., van der Pompe G., ter Horst G.J., den Boer J.A., Korf J. Future antidepressants: what is in the pipeline and what is missing?. CNS Drugs 2004, 18:705-732.
8. Croker B.A., Krebs D.L., Zhang J.G., Wormald S., Willson T.A., Stanley E.G., Robb L., Greenhalgh C.J., Forster I., Clausen B.E., Nicola N.A., Metcalf D., Hilton D.J., Roberts A.W., Alexander W.S. SOCS3 negatively regulates IL-6 signaling in vivo. Nat. Immunol. 2003, 4:540-545.
9. Daban C., Vieta E., Mackin P., Young A.H. Hypothalamic-pituitary-adrenal axis and bipolar disorder. Psychiatr. Clin. North. Am. 2005, 28:469-480.
10. Dantzer R., Capuron L., Irwin M.R., Miller A.H., Ollat H., Perry V.H., Rousey S., Yirmiya R. Identification and treatment of symptoms associated with inflammation in medically ill patients. Psychoneuroendocrinology 2008, 33:18-29.
11. Ernst M., Jenkins B.J. Acquiring signalling specificity from the cytokine receptor gp130. Trends Genet. 2004, 20:23-32.
12. Frank M.G., Barrientos R.M., Watkins L.R., Maier S.F. Aging sensitizes rapidly isolated hippocampal microglia to LPS ex vivo. J. Neuroimmunol. 2010, 226:181-184.
13. Galic M.A., Riazi K., Pittman Q.J. Cytokines and brain excitability. Front. Neuroendocrinol. 2012, 33:116-125.
14. Garcia-Oscos F., Salgado H., Hall S., Thomas F., Farmer G.E., Bermeo J., Galindo L.C., Ramirez R.D., D'Mello S., Rose-John S., Atzori M. The stress-induced cytokine interleukin-6 decreases the inhibition/excitation ratio in the rat temporal cortex via trans-signaling. Biol. Psychiatry 2012, 71:574-582.
15. Gautron L., Lafon P., Tramu G., Laye S. In vivo activation of the interleukin-6 receptor/gp130 signaling pathway in pituitary corticotropes of lipopolysaccharide-treated rats. Neuroendocrinology 2003, 77:32-43.
16. Ghorbel M.T., Sharman G., Leroux M., Barrett T., Donovan D.M., Becker K.G., Murphy D. Microarray analysis reveals interleukin-6 as a novel secretory product of the hypothalamo-neurohypophyseal system. J. Biol. Chem. 2003, 278:19280-19285.
17. Gillespie C.F., Nemeroff C.B. Hypercortisolemia and depression. Psychosom. Med. 2005, 67(Suppl. 1):S26-S28.
18. Girotti M., Donegan J.J., Morilak D.A. Chronic intermittent cold stress sensitizes neuro-immune reactivity in the rat brain. Psychoneuroendocrinology 2011, 36:1164-1174.
19. Girotti M., Donegan J.J., Morilak D.A. Determining the role of hypothalamic IL-6 in sensitization of the rat HPA axis by exposure to chronic cold stress. Soc. Neurosci. 2011, Abstr. 37 (online program 87.03).
20. Girotti M., Pace T.W., Gaylord R.I., Rubin B.A., Herman J.P., Spencer R.L. Habituation to repeated restraint stress is associated with lack of stress-induced c-fos expression in primary sensory processing areas of the rat brain. Neuroscience 2006, 138:1067-1081.
21. Gonzalez-Hernandez J.A., Bornstein S.R., Ehrhart-Bornstein M., Spath-Schwalbe E., Jirikowski G., Scherbaum W.A. Interleukin-6 messenger ribonucleic acid expression in human adrenal gland in vivo: new clue to a paracrine or autocrine regulation of adrenal function. J. Clin. Endocrinol. Metab. 1994, 79:1492-1497.
22. Gonzalez-Hernandez T., Afonso-Oramas D., Cruz-Muros I., Barroso-Chinea P., Abreu P., del Mar Perez-Delgado M., Rancel-Torres N., del Carmen Gonzalez M. Interleukin-6 and nitric oxide synthase expression in the vasopressin and corticotrophin-releasing factor systems of the rat hypothalamus. J. Histochem. Cytochem. 2006, 54:427-441.
23. Gustafsson P.E., Gustafsson P.A., Ivarsson T., Nelson N. Diurnal cortisol levels and cortisol response in youths with obsessive-compulsive disorder. Neuropsychobiology 2008, 57:14-21.
24. Hanisch A., Dieterich K.D., Dietzmann K., Ludecke K., Buchfelder M., Fahlbusch R., Lehnert H. Expression of members of the interleukin-6 family of cytokines and their receptors in human pituitary and pituitary adenomas. J. Clin. Endocrinol. Metab. 2000, 85:4411-4414.
25. Haroon E., Raison C.L., Miller A.H. Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior. Neuropsychopharmacology 2011, 37:137-162.
26. Herman J.P., Adams D., Prewitt C. Regulatory changes in neuroendocrine stress-integrative circuitry produced by a variable stress paradigm. Neuroendocrinology 1995, 61:180-190.
27. Hill M.N., Hellemans K.G., Verma P., Gorzalka B.B., Weinberg J. Neurobiology of chronic mild stress: parallels to major depression. Neurosci. Biobehav. Rev. 2012, 36:2085-2117.
28. Hueston C.M., Barnum C.J., Eberle J.A., Ferraioli F.J., Buck H.M., Deak T. Stress-dependent changes in neuroinflammatory markers observed after common laboratory stressors are not seen following acute social defeat of the Sprague Dawley rat. Physiol. Behav. 2010, 104:187-198.
29. Jankord R., Turk J.R., Schadt J.C., Casati J., Ganjam V.K., Price E.M., Keisler D.H., Laughlin M.H. Sex difference in link between interleukin-6 and stress. Endocrinology 2007, 148:3758-3764.
30. Jankord R., Zhang R., Flak J.N., Solomon M.B., Albertz J., Herman J.P. Stress activation of IL-6 neurons in the hypothalamus. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2010, 299:R343-R351.
31. Jones S.A., Scheller J., Rose-John S. Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling. J. Clin. Invest. 2011, 121:3375-3383.
32. Kageyama K., Watanobe H., Takebe K. In vivo evidence that arginine vasopressin is involved in the adrenocorticotropin response induced by interleukin-6 but not by tumor necrosis factor-alpha in the rat. Neuroimmunomodulation 1995, 2:137-140.
33. Kang J.G., Majerciak V., Uldrick T.S., Wang X., Kruhlak M., Yarchoan R., Zheng Z.M. Kaposi's sarcoma-associated herpesviral IL-6 and human IL-6 open reading frames contain miRNA binding sites and are subject to cellular miRNA regulation. J. Pathol. 2011, 225:378-389.
34. Kariagina A., Zonis S., Afkhami M., Romanenko D., Chesnokova V. Leukemia inhibitory factor regulates glucocorticoid receptor expression in the hypothalamic-pituitary-adrenal axis. Am. J. Physiol. Endocrinol. Metab. 2005, 289:E857-E863.
35. Kehne J.H., Cain C.K. Therapeutic utility of non-peptidic CRF1 receptor antagonists in anxiety, depression, and stress-related disorders: evidence from animal models. Pharmacol. Ther. 2010, 128:460-487.
36. Koo J.W., Russo S.J., Ferguson D., Nestler E.J., Duman R.S. Nuclear factor-kappaB is a critical mediator of stress-impaired neurogenesis and depressive behavior. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:2669-2674.
37. Langlais D., Couture C., Balsalobre A., Drouin J. The Stat3/GR interaction code: predictive value of direct/indirect DNA recruitment for transcription outcome. Mol. Cell 2012, 47:38-49.
38. Laye S., Parnet P., Goujon E., Dantzer R. Peripheral administration of lipopolysaccharide induces the expression of cytokine transcripts in the brain and pituitary of mice. Brain Res. Mol. Brain Res. 1994, 27:157-162.
39. Lenze E.J., Mantella R.C., Shi P., Goate A.M., Nowotny P., Butters M.A., Andreescu C., Thompson P.A., Rollman B.L. Elevated cortisol in older adults with generalized anxiety disorder is reduced by treatment: a placebo-controlled evaluation of escitalopram. Am. J. Geriatr. Psychiatry 2011, 19:482-490.
40. Lerner L., Henriksen M.A., Zhang X., Darnell J.E. STAT3-dependent enhanceosome assembly and disassembly: synergy with GR for full transcriptional increase of the alpha 2-macroglobulin gene. Genes Dev. 2003, 17:2564-2577.
41. Levy B.H., Tasker J.G. Synaptic regulation of the hypothalamic-pituitary-adrenal axis and its modulation by glucocorticoids and stress. Front. Cell. Neurosci. 2012, 6:24.
42. Li Q.L., Jansen E., Friedman T.C. Regulation of prohormone convertase 1 (PC1) by gp130-related cytokines. Mol. Cell. Endocrinol. 1999, 158:143-152.
43. Lyson K., McCann S.M. Induction of adrenocorticotropic hormone release by interleukin-6 in vivo and in vitro. Ann. N. Y. Acad. Sci. 1992, 650:182-185.
44. Ma S., Morilak D.A. Chronic intermittent cold stress sensitises the hypothalamic-pituitary-adrenal response to a novel acute stress by enhancing noradrenergic influence in the rat paraventricular nucleus. J. Neuroendocrinol. 2005, 17:761-769.
45. Ma X.M., Levy A., Lightman S.L. Emergence of an isolated arginine vasopressin (AVP) response to stress after repeated restraint: a study of both AVP and corticotropin-releasing hormone messenger ribonucleic acid (RNA) and heteronuclear RNA. Endocrinology 1997, 138:4351-4357.
46. Marz P., Otten U., Rose-John S. Neural activities of IL-6-type cytokines often depend on soluble cytokine receptors. Eur. J. Neurosci. 1999, 11:2995-3004.
47. McEwen B.S. Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol. Rev. 2007, 87:873-904.
48. Monje F.J., Cabatic M., Divisch I., Kim E.J., Herkner K.R., Binder B.R., Pollak D.D. Constant darkness induces IL-6-dependent depression-like behavior through the NF-kappaB signaling pathway. J. Neurosci. 2011, 31:9075-9083.
49. Nishimoto N., Kanakura Y., Aozasa K., Johkoh T., Nakamura M., Nakano S., Nakano N., Ikeda Y., Sasaki T., Nishioka K., Hara M., Taguchi H., Kimura Y., Kato Y., Asaoku H., Kumagai S., Kodama F., Nakahara H., Hagihara K., Yoshizaki K., Kishimoto T. Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease. Blood 2005, 106:2627-2632.
50. Pace T.W., Mletzko T.C., Alagbe O., Musselman D.L., Nemeroff C.B., Miller A.H., Heim C.M. Increased stress-induced inflammatory responses in male patients with major depression and increased early life stress. Am. J. Psychiatry 2006, 163:1630-1633.
51. Raber J., Sorg O., Horn T.F., Yu N., Koob G.F., Campbell I.L., Bloom F.E. Inflammatory cytokines: putative regulators of neuronal and neuro-endocrine function. Brain Res. Brain Res. Rev. 1998, 26:320-326.
52. Refojo D., Holsboer F. CRH signaling molecular specificity for drug targeting in the CNS. Ann. N. Y. Acad. Sci. 2009, 1179:106-119.
53. Sarlis N.J., Stephanou A., Knight R.A., Lightman S.L., Chowdrey H.S. Effects of glucocorticoids and chronic inflammatory stress upon anterior pituitary interleukin-6 mRNA expression in the rat. Br. J. Rheumatol. 1993, 32:653-657.
54. Scaccianoce S., Muscolo L.A., Cigliana G., Navarra D., Nicolai R., Angelucci L. Evidence for a specific role of vasopressin in sustaining pituitary-adrenocortical stress response in the rat. Endocrinology 1991, 128:3138-3143.
55. Schmidt H.D., Shelton R.C., Duman R.S. Functional biomarkers of depression: diagnosis, treatment, and pathophysiology. Neuropsychopharmacology 2011, 36:2375-2394.
56. Schobitz B., Pezeshki G., Pohl T., Hemmann U., Heinrich P.C., Holsboer F., Reul J.M. Soluble interleukin-6 (IL-6) receptor augments central effects of IL-6 in vivo. FASEB J. 1995, 9:659-664.
57. Siewert E., Muller-Esterl W., Starr R., Heinrich P.C., Schaper F. Different protein turnover of interleukin-6-type cytokine signalling components. Eur. J. Biochem. 1999, 265:251-257.
58. Spinedi E., Hadid R., Daneva T., Gaillard R.C. Cytokines stimulate the CRH but not the vasopressin neuronal system: evidence for a median eminence site of interleukin-6 action. Neuroendocrinology 1992, 56:46-53.
59. Steptoe A., Hamer M., Chida Y. The effects of acute psychological stress on circulating inflammatory factors in humans: a review and meta-analysis. Brain Behav. Immun. 2007, 21:901-912.
60. Stylianou E., Saklatvala J. Interleukin-1. Int. J. Biochem. Cell Biol. 1998, 30:1075-1079.
61. Sun J., Blaskovich M.A., Jove R., Livingston S.K., Coppola D., Sebti S.M. Cucurbitacin Q: a selective STAT3 activation inhibitor with potent antitumor activity. Oncogene 2005, 24:3236-3245.
62. Vallieres L., Rivest S. Regulation of the genes encoding interleukin-6, its receptor, and gp130 in the rat brain in response to the immune activator lipopolysaccharide and the proinflammatory cytokine interleukin-1beta. J. Neurochem. 1997, 69:1668-1683.
63. Van Houdenhove B., Van Den Eede F., Luyten P. Does hypothalamic-pituitary-adrenal axis hypofunction in chronic fatigue syndrome reflect a 'crash' in the stress system?. Med. Hypotheses 2009, 72:701-705.
64. Yehuda R. Advances in understanding neuroendocrine alterations in PTSD and their therapeutic implications. Ann. N. Y. Acad. Sci. 2006, 1071:137-166.
65. Yoshimura A., Naka T., Kubo M. SOCS proteins, cytokine signalling and immune regulation. Nat. Rev. Immunol. 2007, 7:454-465.
66. Zhou D., Kusnecov A.W., Shurin M.R., DePaoli M., Rabin B.S. Exposure to physical and psychological stressors elevates plasma interleukin 6: relationship to the activation of hypothalamic-pituitary-adrenal axis. Endocrinology 1993, 133:2523-2530.